Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Integra LifeSciences Corporation
The purpose of this study is to collect additional safety data and demonstrate the performance of Integra Gentrix® Surgical Matrix for reinforcement of ventral hernia repairs from a sub-population of twenty-one participants from the previous T-GENVIH-002 study, specifically those with laparoscopic or robotic repair. Prospective data will be collected via a one-off study follow-up visit and assessed for later post-operative surgical site events and complications in the post-operative period from the last timepoint of data collection in T-GENVIH-002 to present.
Age
22–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient was a subject in the T-GENVIH-002 study and underwent minimally invasive (i.e., laparoscopic or robotic) abdominal wall reconstruction for a primary hernia using Integra® Gentrix® Surgical Matrix.
Subject has participated in the informed consent process and signed a study-specific informed consent document.
Subject is fluent in US English or US Spanish language.
Subject is willing to complete an e-consent and phone or in-office visit.
You may not be if
Not applicable.
Clareo Health | T-GENVIH-003 LTFU (Long Term Follow Up) Study
